Intraoperative use of cell saver devices decreases the rate of hyperlactatemia in patients undergoing cardiac surgery.

Zhou, Yenong; Yang, Chen; Jin, Zhenxiao; Zhang, Bing

Zhou, Yenong; Yang, Chen; Jin, Zhenxiao; Zhang, Bing.

Afiliação

Zhou Y; Department of Cardiovascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Yang C; Department of Cardiovascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Jin Z; Department of Cardiovascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Zhang B; Department of Cardiovascular Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Heliyon ; 9(5): e15999, 2023 May.

Article em En | MEDLINE | ID: mdl-37215823

Palavras-chave

Cardiopulmonary bypass; Cell saver; Hyperlactatemia; Prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Heliyon Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google